Artesunate attenuates bone erosion in rheumatoid arthritis by suppressing reactive oxygen species via activating p62/Nrf2 signaling
Open Access
- 1 May 2021
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 137, 111382
Abstract
No abstract availableKeywords
Funding Information
- Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park
- National Natural Science Foundation of China
This publication has 34 references indexed in Scilit:
- Pseurotin A Inhibits Osteoclastogenesis and Prevents Ovariectomized-Induced Bone Loss by Suppressing Reactive Oxygen SpeciesTheranostics, 2019
- RETRACTED: Effects of Artesunate on chondrocyte proliferation, apoptosis and autophagy through the PI3K/AKT/mTOR signaling pathway in rat models with rheumatoid arthritisBiomedicine & Pharmacotherapy, 2018
- DJ-1 controls bone homeostasis through the regulation of osteoclast differentiationNature Communications, 2017
- Oxidative stress as a potential biomarker for determining disease activity in patients with Rheumatoid ArthritisFree Radical Research, 2012
- Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatmentNature Reviews Rheumatology, 2012
- The Pathogenesis of Rheumatoid ArthritisNew England Journal of Medicine, 2011
- Resveratrol prevents RANKL-induced osteoclast differentiation of murine osteoclast progenitor RAW 264.7 cells through inhibition of ROS productionBiochemical and Biophysical Research Communications, 2010
- A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiationBlood, 2005
- Thioredoxin as a biomarker for oxidative stress in patients with rheumatoid arthritisMolecular Immunology, 2002
- Participation of oxidative stress in the process of osteoclast differentiationBiochimica et Biophysica Acta (BBA) - General Subjects, 1993